Nordic Capital and Astorg to sell Clario to Thermo Fisher for $8.9bn
Nordic Capital and Astorg have agreed to sell their co-controlling stakes in Clario, a provider of digital endpoint solutions for clinical trials, to Thermo Fisher Scientific in an all-cash transaction reportedly valued at around $8.9bn.